Fig. 2From: Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinomaPDX and PDTO recapitulate the heterogeneity of histologic features and expression of OCCC markers of the original tumor. Comparative histologic, morphologic and IHC images of tumor-derived models (PDX, PDTO and cell lines) compared with the original tumor. Top row, H&E staining of patient tumor, PDTOs and PDX and Giemsa staining of tumor-derived cell lines. Next rows, IHC staining of Ki-67, PAX8, p53, WT1 and HNF1B. Scale bar: 100µmBack to article page